Latest News

Allison Transmission Holdings has reorganized into two business units, Allison Transmission and Allison Off-Highway Drive & Motion Systems, with Fred Bohley and newly appointed executive Craig Price leading the units and reporting to CEO David Graziosi. The hiring of Price from Dana’s Off-Highway business, alongside his long tenure in purchasing and supplier development, signals a push to tightly manage costs and extract efficiencies from the recently acquired operations. Next, we’ll examine...

Austal (ASX:ASB) has hit an all time high after securing a Strategic Shipbuilding Agreement with the Australian Government worth an initial A$1b to A$1.3b and expanding its U.S. shipyard operations. See our latest analysis for Austal. That agreement and the U.S. yard expansion sit on top of strong recent momentum, with a 30 day share price return of 33.74% and a 1 year total shareholder return of 178.10% signaling that investors are aggressively repricing Austal’s defence exposure. If...

Baird’s downgrade of Sunstone Hotel Investors (SHO) from Outperform to Neutral puts fresh attention on the REIT’s positioning versus peers, particularly given its consistent dividend history and current 3.82% yield. See our latest analysis for Sunstone Hotel Investors. The Baird downgrade comes after a mixed run for the stock, with a 1-day share price return of 1.08% and a 30-day share price return of 1.30%, set against a 1-year total shareholder return decline of 16.11%. Taken together, this...

December sales update and why it matters for shareholders Country Garden Holdings (SEHK:2007) has released preliminary unaudited sales figures for December 2025, reporting contracted sales attributable to shareholders of about RMB 2.69b and contracted sales gross floor area of roughly 0.31 million square meters. For investors tracking this China focused developer, these monthly numbers provide another reference point alongside the company’s recent share price performance, multi year total...

There wouldn't be many who think Edelweiss Financial Services Limited's ( NSE:EDELWEISS ) price-to-earnings (or "P/E...

As Middle Eastern stock markets experience gains fueled by rising oil prices, investors are closely watching the impact of geopolitical tensions and shifts in U.S. economic policy on regional indices. In this dynamic environment, identifying promising stocks involves assessing companies that can leverage these macroeconomic trends while demonstrating resilience and growth potential.

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...

Key Insights Significantly high institutional ownership implies Bank Leumi le-Israel B.M's stock price is sensitive to...

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

Titomic Limited has announced leadership changes within its European division, with Chris Myers becoming President of Titomic Europe in early 2026 and Ferdy Touwen promoted to Deputy President & Head of European Operations, while outgoing leader Klaas Rozema moves into a Senior Executive Advisor role ahead of a planned sabbatical. This reshaping of Titomic’s European leadership concentrates commercial and operational responsibility in a refreshed team, aiming to support execution, customer...

Arcturus Therapeutics Holdings Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at the Westin St. Francis Hotel in San Francisco, with Founder, President, CEO and Director Joseph E. Payne speaking. This high-profile conference appearance offered Arcturus a platform to showcase its pipeline and corporate story to a concentrated audience of healthcare-focused investors and industry peers. With this conference spotlight and recent share price...

If you are wondering whether Daiichi Sankyo Company’s current share price reflects its true worth, you are not alone. This article is designed to help you make sense of that question. The stock last closed at ¥3,540, with returns of 2.6% over 7 days, 5.3% over 30 days, a modest 0.3% year to date, and a 13.1% decline over 1 year. The 3 year and 5 year returns sit at 9.7% and roughly 0% respectively. Recent coverage of Daiichi Sankyo has focused on its position in the pharmaceuticals and...

Masimo Corporation has already presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and released preliminary fourth-quarter and full-year 2025 results indicating approximately 12% quarterly and 9% annual revenue growth. Management also highlighted a record level of incremental contract value from new and expanded hospital agreements, underscoring the importance of long-term customer relationships to the business. We’ll now examine how the record incremental...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Key Insights The projected fair value for Inspiration Healthcare Group is UK£0.099 based on 2 Stage Free Cash Flow to...

Honat Bancorp (HONT) has put another solid quarter on the board, with Q2 2025 revenue of US$11.4 million and basic EPS of US$2.57 feeding into trailing twelve month EPS of US$10.46 on revenue of US$44.6 million and net income of US$15.0 million. Over the past year, the company has seen revenue move from US$38.8 million to US$44.6 million on a trailing basis, while EPS climbed from US$8.33 to US$10.46, and earnings growth of 19% has supported a net profit margin of 33.5% compared with 31.2% a...

If you are wondering whether Fidelity National Information Services is priced attractively right now, you are not alone. Many investors are asking if the current share price lines up with the company’s underlying value. The stock recently closed at US$64.23, with returns of a 4.2% decline over 7 days, a 4.3% decline over 30 days, a 2.1% decline year to date, a 16.2% decline over 1 year, and a 44.0% decline over 5 years, which may influence how you think about its potential and its...

Immunovant (IMVT) has been drawing attention after recent share moves that contrast a loss-making profile with fast annual growth in revenue and net income metrics, raising questions about how investors are weighing its clinical-stage risks. See our latest analysis for Immunovant. At a share price of $26.18, Immunovant’s recent 1 day share price return of 1.43% and 90 day share price return of 46.01% sit alongside a 1 year total shareholder return of 14.42% and 3 year total shareholder return...

If you have been wondering whether Sika shares are now offering value or still look expensive, this breakdown will help you put the current price into context before you commit fresh capital. Sika shares last closed at CHF149.10, with returns of an 8.7% decline over 7 days, a 6.7% decline over 30 days, an 8.9% decline year to date, and a 30.8% decline over 1 year, adding to a 39.6% decline over 3 years and a 35.0% decline over 5 years. Recent coverage around Sika has focused on its position...

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market pressures, there remain opportunities for investors willing to explore beyond the mainstream indices. Penny stocks, often representing smaller or newer companies, can still offer potential growth when they are underpinned by strong financials and sound fundamentals.

Astra Industrial Group (TADAWUL:1212) has had a great run on the share market with its stock up by a significant 14...

Key Insights Given the large stake in the stock by institutions, Avacta Group's stock price might be vulnerable to...

If you are wondering whether J. M. Smucker's current share price fairly reflects its long term value, you are not alone. This article is built to unpack exactly that question. The stock last closed at US$101.61, with returns of 5.9% over the past 7 days, 5.2% year to date and 3.8% over the last year. The 3 year return sits at a 27.3% decline and the 5 year return at 3.7%. Recent coverage around J. M. Smucker has focused on its position in packaged foods and consumer staples, as investors...